Fundraising Fox
Brandon Capital Partners
Venture capitalMelbourne · Seed–Growth · 1 people tracked
Find your way into Brandon Capital Partners
Sign up to see every warm intro you have to Brandon Capital Partners
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Brandon Capital Partners team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
Brandon Capital is a life sciences venture capital firm that invests in biotech and medical research companies, with investors and venture partners across Australia, New Zealand, the United States and the United Kingdom.
Source: firm website, verified Sep 20, 2026.
Team · 1 people
from the firm's website
Chris joined Brandon Capital in 2012 and previously worked as a Business Development Manager at CSL and as a postdoctoral scientist at the University of Cambridge. He serves as a director of several portfolio companies including Aravax, Denteric, Ena Respiratory, MycRx, Q-Sera and Axelia Oncology, and holds a PhD in Immunology and an MBA from Cambridge.
What they invest in
from 6 of 7 portfolio companiesBiotech ×6Medical Devices ×4Digital Health ×3Healthtech ×3Deep Tech ×2Impact & Social Good ×1Longevity ×1
HQs:Australia×3United States×2United Kingdom×1
Investments · 7 tracked
founders shown can be your intro path
Amaroq Therapeutics develops first-in-class therapies targeting long non-coding RNAs (lncRNAs) implicated in oncology and other diseases.
Biotech
Co-investorsBooster Innovation FundCure Kids VenturesTenmileBrandon Capital
Brandon BioCatalyst funds biomedical development opportunities associated with its Member Institutes, offering investments ranging from AU$500,000 to AU$30 million across stages from proof-of-concept to late-stage technologies.
BiotechDeep TechDigital HealthHealthtechImpact & Social GoodMedical Devices
Co-investorsBrandon Capital
George Medicines develops single-pill combination therapies for cardiometabolic diseases such as hypertension and diabetes, leveraging research from The George Institute for Global Health.
BiotechDigital HealthHealthtechMedical Devices
Mark Mallon(Chief Executive Officer)inProfessor Anthony Rodgers(Chief Medical Officer)Dr Karl Roberts(Chief Operating Officer)in
Co-investorsBrandon BioCatalystBrandon Capital
Glyscend Therapeutics is a clinical-stage biopharmaceutical company developing oral, first-in-class therapies for type 2 diabetes and obesity.
BiotechDeep TechDigital HealthHealthtechLongevityBaltimore, US
Ashish Nimgaonkar(Executive Officer, Director)Dennis McWilliams(Director)inCasey Cunningham(Director)Leighton Read(Director)inBob Soh(Director)in
Co-investorsBrandon BioCatalystBreakout Labs
Myricx Bio is a biotech company developing antibody drug conjugates (ADCs) based on N-myristoyltransferases (NMT) inhibitors for cancer treatment.
BiotechMedical DevicesLondon, GB
Co-investorsBrandon CapitalNovo HoldingsSofinnova PartnersAbingworth
An online gambling platform licensed under Curacao eGaming, offering video slots, live dealer tables, progressive jackpots, and specialty games from studios such as NetEnt, Microgaming, and Pragmatic Play.
Co-investorsStoic VCBrandon BioCatalyst
Brandon Capital is a venture capital firm that transforms medical research breakthroughs into therapeutic products, supporting life science companies from early-stage through commercialization.
BiotechMedical DevicesSan Francisco, US
Co-investorsBrandon BioCatalystAirTree VenturesGolden Gate VenturesLINE Ventures
Portfolio news
latest coverage across their companies
Myricx Bio · techfundingnews.com · Jul 6, 2026
Frequently asked questions
- How many investments has Brandon Capital Partners made?
- Brandon Capital Partners has 7 tracked investments.
- What stage does Brandon Capital Partners invest at?
- Brandon Capital Partners invests at the Seed, Series A, Series B, Series C, Growth stages.
- What sectors does Brandon Capital Partners focus on?
- Brandon Capital Partners focuses on Biotech, Deep Tech, Digital Health, Healthtech, Medical Devices.
- Where is Brandon Capital Partners located?
- Brandon Capital Partners is headquartered in Melbourne, AU.
- Who does Brandon Capital Partners co-invest with?
- Brandon Capital Partners most often shares deals with Brandon Capital, Brandon BioCatalyst, Novo Holdings, among 4 tracked co-investors.
Images
Similar investors
Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests in technology companies from seed to growth stage. Since inception it has backed over 200 companies and raised more than $1.3 billion.
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
Capricorn Partners is an independent manager of venture capital funds and the listed investment company Quest for Growth, backing innovative companies that use technology as a competitive advantage.
Norwest is a venture capital and growth equity investment firm that has backed over 700 companies across technology, consumer, and healthcare over its 65-year history.
Bayern Kapital is a public venture capital and growth investor backing innovative Bavarian high-tech, deep tech and life sciences start-ups and scale-ups, acting as an anchor investor across multiple funding rounds.